Pharmacokinetics of cefazolin in normal and uremic subjects.
D000328:Adult; D001681:Biological Assay; D001798:Blood Proteins / Q000378:metabolism; D002511:Cephalosporins / Q000008:administration & dosage / Q000097:blood / Q000378:metabolism* / Q000494:pharmacology / Q000652:urine; D005260:Female; D006207:Half-Life; D006801:Humans; D007676:Kidney Failure, Chronic / Q000378:metabolism; D007700:Kinetics; D008297:Male; D011485:Protein Binding; D013210:Staphylococcus / Q000187:drug effects; D013440:Sulfides / Q000008:administration & dosage / Q000097:blood / Q000378:metabolism / Q000494:pharmacology / Q000652:urine; D013777:Tetrazoles / Q000008:administration & dosage / Q000097:blood / Q000378:metabolism / Q000494:pharmacology / Q000652:urine; D013830:Thiadiazoles / Q000008:administration & dosage / Q000097:blood / Q000378:metabolism / Q000494:pharmacology / Q000652:urine; D013997:Time Factors; D014511:Uremia / Q000097:blood / Q000378:metabolism* / Q000652:urine
D001798:Blood Proteins; D002511:Cephalosporins; D013440:Sulfides; D013777:Tetrazoles; D013830:Thiadiazoles